Botox & Dermal Fillers

Deigni Plastic Surgery offers Botox and dermal filler treatments as part of a non-surgical aesthetic menu. Botox and neuromodulators smooth dynamic wrinkles of the forehead, glabellar complex, and crow's feet, with results lasting three to four months. Dermal fillers restore facial volume, enhance the lips, and soften static folds including nasolabial and marionette lines, with results lasting six to eighteen months depending on the product and area treated. Non-surgical treatments are performed by the clinical team at the Houston practice and are planned to complement surgical outcomes where both are sought.

Botox and dermal filler treatments at Deigni Plastic Surgery in Houston sit within a coordinated aesthetic programme that bridges non-surgical maintenance and surgical rejuvenation. For patients who have undergone a facelift, rhinoplasty, or eyelid surgery at the practice, non-surgical treatments provide ongoing maintenance between procedures; for patients considering surgery in the future, injectable treatments offer an interim option that preserves facial volume and delays the acceleration of dynamic wrinkle formation. Botulinum toxin type A (Botox, Dysport) injections work by transiently blocking acetylcholine release at the neuromuscular junction in targeted facial muscles, reducing the force of muscle contraction and allowing the overlying skin to smooth. Primary treatment zones at the practice include the frontalis (horizontal forehead lines), the corrugator supercilii and procerus complex (vertical glabellar frown lines), and the orbicularis oculi (crow's feet at the lateral canthus). Additional applications include masseter reduction for non-surgical jaw slimming in patients with hypertrophic masseters, brow lifting via targeted depressor relaxation, platysma band softening for the neck, and lip flip via orbicularis oris injection. Injections are dosed with precision — forehead treatments typically 10–20 units, glabella 20–25 units, crow's feet 10–15 units per side — and results are assessed at a two-week follow-up. Dermal fillers at the practice use hyaluronic acid products from the Juvederm and Restylane families: thicker, higher-G-prime formulations for structural mid-face volumising and cheek restoration (Voluma, Sculptra adjacent protocols); intermediate formulations for nasolabial fold and marionette line softening; and softer formulations for lip augmentation and perioral hydration. Filler injection at a practice led by a board-certified plastic surgeon carries the added safety margin of immediate access to hyaluronidase for reversal and a thorough understanding of facial vascular anatomy to minimise the risk of inadvertent intravascular injection. All injectable treatments are planned in the context of the patient's full facial anatomy and aesthetic goals, with natural-looking outcomes as the guiding principle.